A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3192-3193

  Mariat, C ^a   Afiani, A ^a   Alamartine, E ^a   Thibaudin, D ^a   De Filippis, J P ^a   Berthoux, F ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; LYMPHOCYTE COUNT; PILOT STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS;

EID: 0035675696     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02357-0     Document Type: Article

References (6)

1. Thibaudin D, Alamartine E, de Filippis JP, et al: Nephrol Dial Transplant 13:711, 1998
2. Kahan BD, Rajagopolan PR, Hall M: Transplantation 67:276, 1999
3. Ponticelli C, Yussim A, Cambi V, et al: Transplant Proc 33:1009, 2001
4. Polsky D, Weinfurt KP, Kaplan B, et al: Nephrol Dial Transplant 16:1028, 2001
5. Shah MB, Martin JE, Schroeder TJ, et al: Transplantation 67:1411, 1999
6. Kode RK, Kumar AMS, Pankewycz O, et al: Transplant Proc 33:1268, 2001